Skip to main content
logo
Invex Therapeutics Ltd (ASX:IXC)
Australia flag Australia · Delayed Price · Currency is AUD
0.1150
0.00 (0.00%)
Sep 16, 2026, 12:33 PM AEST

Invex Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
97751537
Market Cap Growth
15.00%1.12%48.33%-70.00%-59.60%-21.43%
Enterprise Value
521-2-106
Last Close Price
0.120.090.090.060.050.13

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
184.57144.4529.203.7232.74204.12
PB Ratio
2.211.731.270.790.711.31
P/TBV Ratio
2.211.731.270.790.711.31

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
98.8046.313.85--32.02

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-1.03-1.03-1.02-1.06-1.06-1.03
Asset Turnover
0.010.010.040.080.020.01
Quick Ratio
26.4826.4824.7914.1814.5029.36
Current Ratio
26.4826.4824.7914.1814.5029.36
Return on Equity (ROE)
-29.54%-29.54%-8.72%-12.20%-31.18%-13.05%
Return on Assets (ROA)
-19.64%-19.64%-7.65%-9.22%-20.43%-8.10%
Return on Capital Employed (ROCE)
-38.30%-38.30%-13.50%-37.50%-40.30%-14.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-15.65%-19.99%-7.13%-36.41%-51.56%-10.63%
Buyback Yield / Dilution
0.74%0.74%-0.51%-0.19%-0.02%-0.03%